Centene is trading 4% up at $66.45, rebounding from recent weakness as strong UnitedHealth earnings boost sentiment across the managed care space.
- The stock is recovering from recent pressure tied to Medicaid eligibility redetermination concerns.
- Positive momentum follows a broad healthcare sector rally, lifting health insurers despite ongoing regulatory headwinds for Medicaid-focused players.
- UnitedHealth's strong performance has improved investor confidence in the broader managed care and health insurance industry.